HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
25 sources retrieved Β· Most recent: April 2026 Β· Index updated 14 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
TCERG1
transcription elongation regulator 1
Chromosome 5 Β· 5q32
NCBI Gene: 10915Ensembl: ENSG00000113649.14HGNC: HGNC:15630UniProt: A0A7P0T8N8
155PubMed Papers
20Diseases
0Drugs
1Pathogenic Variants
FUNCTIONAL ROLE
Highly ConstrainedHub GeneTranscription Factor
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
transcription corepressor activitypositive regulation of transcription by RNA polymerase IInegative regulation of transcription by RNA polymerase IImRNA processingneurodegenerative diseasesmoking initiationcolorectal cancersleep apnea
✦AI Summary

TCERG1 (transcription elongation regulator 1) is a nuclear transcription factor that couples transcriptional elongation with pre-mRNA splicing. It binds to RNA polymerase II and regulates transcription elongation in a TATA box-dependent manner 1. TCERG1 localizes to both the nucleoplasm and nuclear speckles, where it interacts transiently with both elongation and splicing complexes to coordinate their functions 1. The protein is positioned at the B complex stage of spliceosome assembly 2, and knockdown studies reveal widespread alterations in alternative mRNA processing, including changes to 3'-untranslated regions 3. Mechanistically, TCERG1 exhibits rapid mobility in the nucleus that decreases when associated with active transcription and cotranscriptional splicing sites, suggesting it performs coupling through transient rather than stable interactions 1. Post-translational sumoylation at Lys-503 and Lys-608 negatively regulates its transcriptional activity without affecting splicing function 4. Clinically, TCERG1 is highly expressed in hepatocellular carcinoma and associated with poor prognosis and enhanced cell proliferation, migration, and invasion 5. It is implicated in Huntington's disease pathogenesis, where DNA methylation stabilizes TCERG1-mediated dysregulation of genes controlling enhancer function and transcription elongation 6. TCERG1 depletion impairs neurite outgrowth in neuronal cells, affecting genes involved in cytoskeleton dynamics 7.

Sources cited
1
TCERG1 couples transcriptional elongation with splicing through transient interactions with both complexes, with mobility properties indicating interaction with paused elongation and spliceosomal complexes
PMID: 26873599
2
TCERG1 is localized to the B complex stage of spliceosome assembly
PMID: 38383864
3
TCERG1 knockdown causes widespread alterations in alternative mRNA processing, particularly of 3'-untranslated regions
PMID: 18187414
4
TCERG1 undergoes sumoylation at Lys-503 and Lys-608, which negatively regulates transcriptional activity but not splicing function
PMID: 20215116
5
TCERG1 is highly expressed in hepatocellular carcinoma and associated with poor prognosis, enhanced proliferation, migration, and invasion
PMID: 36299588
6
TCERG1 is a HD-modifying protein whose regulation by DNA methylation affects enhancer function and transcription elongation in Huntington's disease
PMID: 40501897
7
TCERG1 depletion impairs neurite outgrowth and dendritic branching by affecting alternative splicing of genes involved in cytoskeleton dynamics
PMID: 27844289
Disease Associationsβ“˜20
neurodegenerative diseaseOpen Targets
0.53Moderate
smoking initiationOpen Targets
0.34Weak
colorectal cancerOpen Targets
0.34Weak
sleep apneaOpen Targets
0.32Weak
chronic venous hypertensionOpen Targets
0.29Weak
hyperpituitarismOpen Targets
0.24Weak
joint diseaseOpen Targets
0.23Weak
HypervolemiaOpen Targets
0.21Weak
hepatocellular carcinomaOpen Targets
0.07Suggestive
Huntington diseaseOpen Targets
0.06Suggestive
neoplasmOpen Targets
0.04Suggestive
cancerOpen Targets
0.04Suggestive
Abruptio PlacentaeOpen Targets
0.03Suggestive
rheumatic diseaseOpen Targets
0.03Suggestive
myeloid sarcomaOpen Targets
0.03Suggestive
schizophreniaOpen Targets
0.03Suggestive
sialadenitisOpen Targets
0.02Suggestive
cholelithiasisOpen Targets
0.02Suggestive
liver cancerOpen Targets
0.01Suggestive
Growth Hormone-Producing Pituitary Gland AdenomaOpen Targets
0.01Suggestive
Pathogenic Variants1
NM_001382548.1(TCERG1):c.192del (p.Pro65fs)Pathogenic
Colorectal cancer
β˜†β˜†β˜†β˜†β†’ Residue 65
View on ClinVar β†—
Related Genes
SNW1Protein interaction100%BUD31Protein interaction100%CDC5LProtein interaction100%CWC15Protein interaction100%PRPF8Protein interaction100%SNRPA1Protein interaction100%
Tissue Expression6 tissues
Bone Marrow
100%
Ovary
50%
Lung
34%
Heart
30%
Brain
28%
Liver
26%
Gene Interaction Network
Click a node to explore
TCERG1SNW1BUD31CDC5LCWC15PRPF8SNRPA1
PROTEIN STRUCTURE
Preparing viewer…
PDB3Q1I Β· 1.40 Γ… Β· X-ray
View on RCSB β†—
Constraintβ“˜
LOEUFβ“˜
0.32Highly Constrained
pLIβ“˜
1.00Intolerant
Observed/Expected LoF0.24 [0.17–0.32]
RankingsWhere TCERG1 stands among ~20K protein-coding genes
  • #2,925of 20,598
    Most Researched155 Β· top quartile
  • #4,773of 5,498
    Most Pathogenic Variants1
  • #1,314of 17,882
    Most Constrained (LOEUF)0.32 Β· top 10%
Genes detectedTCERG1
Sources retrieved25 papers
Response timeβ€”
πŸ“„ Sources
25β–Ό
1
Cryo-EM analyses of dimerized spliceosomes provide new insights into the functions of B complex proteins.
PMID: 38383864
EMBO J Β· 2024
1.00
2
A new optimized formulation of cationic solid lipid nanoparticles intended for gene delivery: development, characterization and DNA binding efficiency of TCERG1 expression plasmid.
PMID: 24999055
Int J Pharm Β· 2014
0.90
3
The in vivo dynamics of TCERG1, a factor that couples transcriptional elongation with splicing.
PMID: 26873599
RNA Β· 2016
0.80
4
Genetic locus responsible for diabetic phenotype in the insulin hyposecretion (ihs) mouse.
PMID: 32502168
PLoS One Β· 2020
0.72
5
Overexpression of
PMID: 36299588
Front Genet Β· 2022
0.70